Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis

Ann Rheum Dis. 1994 Aug;53(8):506-10. doi: 10.1136/ard.53.8.506.

Abstract

Objectives: To determine whether fibroblasts from patients with systemic sclerosis (SSc) produce excessive amounts of endothelin-1 (ET-1), which is recognised as having vasoconstrictive properties and as having a potent mitogenic effect on fibroblasts.

Methods: Dermal fibroblasts were removed from 11 patients with SSc and from five normal controls (NC). The assay of ET-1 protein was measured by an ELISA that used two anti-ET-1 antibodies. The gene expression of prepro ET-1 mRNA was evaluated by a reverse-transcriptase polymerase chain reaction (RT-PCR) method.

Results: Levels of ET-1 protein were significantly higher in SSc fibroblast cultures than in those of normal fibroblasts (p < 0.01). The expression of prepro ET-1 mRNA was also higher in SSc fibroblasts than in normal fibroblasts. The addition of interleukin-1 beta (IL-1 beta) increased the production of ET-1 by fibroblasts.

Conclusion: The findings indicate that the overproduction of ET-1 is a novel abnormal function in SSc fibroblasts, and that ET-1 induced by fibroblasts may play a role in the fibrosis and Raynaud's phenomenon of SSc.

MeSH terms

  • Adult
  • Aged
  • Base Sequence
  • Cells, Cultured
  • Endothelins / biosynthesis*
  • Endothelins / genetics
  • Endothelium, Vascular / metabolism
  • Female
  • Fibroblasts / metabolism
  • Humans
  • Interleukin-1 / pharmacology
  • Kinetics
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • RNA, Messenger / genetics
  • Recombinant Proteins / pharmacology
  • Scleroderma, Systemic / metabolism*
  • Skin / metabolism*

Substances

  • Endothelins
  • Interleukin-1
  • RNA, Messenger
  • Recombinant Proteins